TickerFacts.

Exagen Inc. (XGN): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$0.93
Year ended 2025-12-31
2020-12-31: -$1.322021-12-31: -$1.682022-12-31: -$2.772023-12-31: -$1.342024-12-31: -$0.832025-12-31: -$0.93-$0.93
2020-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$0.93n/m2026-03-10, From 2025-01-01
2024-12-31-$0.83n/m2026-03-10, From 2024-01-01
2023-12-31-$1.34n/m2025-03-11, From 2023-01-01
2022-12-31-$2.77n/m2024-03-18, From 2022-01-01
2021-12-31-$1.68n/m2023-03-20, From 2021-01-01
2020-12-31-$1.32n/a2022-03-22, From 2020-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Exagen Inc. (XGN)2025-12-31-$0.93n/m
Personalis, Inc. (PSNL)2025-12-31-$0.91n/m
Biodesix Inc (BDSX)2025-12-31-$4.67n/m
CapForce Inc. (CFOR)2025-12-31$2.32+0.9%
GRAIL, Inc. (GRAL)2025-12-31-$11.11n/m
American Shared Hospital Services (AMS)2025-12-31-$0.23n/m
BillionToOne, Inc. (BLLN)2025-12-31$0.14n/m
Castle Biosciences Inc (CSTL)2025-12-31-$0.83n/m
CareDx, Inc. (CDNA)2025-12-31-$0.40n/m

Compare XGN, PSNL, BDSX, CFOR side by side · Screen every company in Services-Medical Laboratories ↗